Protecting Americans from Fentanyl Trafficking Act of 2021

Bill: 117-s-1410
Sponsor: full_name: Sen. Cotton, Tom [R-AR]
Introduced: 2021-04-28
Policy area: Crime and Law Enforcement
Subjects: Drug trafficking and controlled substances
Latest action: action_date: 2021-04-28
text: Read twice and referred to the Committee on the Judiciary.

Summaries:
action_date: 2021-04-28
action_desc: Introduced in Senate
text: <p><strong>Protecting Americans from Fentanyl Trafficking Act of 2021</strong></p> <p>This bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.</p> <p> The temporary scheduling order issued by the Drug Enforcement Administration to place fentanyl-related substances into schedule I of the Controlled Substances Act expires on January 28, 2022.</p>

tv_txt: II 117th CONGRESS 1st Session S. 1410 IN THE SENATE OF THE UNITED STATES April 28, 2021 Mr. Cotton introduced the following bill; which was read twice and referred to the Committee on the Judiciary A BILL To codify the temporary scheduling order for fentanyl-related substances by adding fentanyl-related substances to schedule I of the Controlled Substances Act.

1. Short title This Act may be cited as the Protecting Americans from Fentanyl Trafficking Act of 2021 . 2. Placement of fentanyl-related substances in schedule I Schedule I of section 202(c) of the Controlled substances Act ( 21 U.S.C. 812(c) ) is amended by adding at the end the following: (e) (1) Fentanyl-related substances, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers. (2) For purposes of paragraph (1), the term fentanyl-related substance means any substance that— (A) is not listed in another schedule; (B) has not been approved under section 505 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355 ) or granted an exemption for investigational use under subsection (i) of such section 505; and (C) is structurally related to fentanyl by— (i) replacement of the phenyl portion of the phenethyl group by any monocycle, whether or not further substituted in or on the monocycle; (ii) substitution in or on the phenethyl group with alkyl, alkenyl, alkoxyl, hydroxyl, halo, haloalkyl, amino, or nitro groups; (iii) substitution in or on the piperidine ring with alkyl, alkenyl, alkoxyl, ester, ether, hydroxyl, halo, haloalkyl, amino, or nitro groups; (iv) replacement of the aniline ring with any aromatic monocycle, whether or not further substituted in or on the aromatic monocycle; or (v) replacement of the N-propionyl group by another acyl group. .